Navigation Links
PharmaTelevision Launches New Premium Content Service
Date:7/15/2009

OXFORD, England, July 15 /PRNewswire/ --

- Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, and Other Big Pharma use New Media to Bring Fresh Exchange

PharmaTelevision, the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service, PharmaTelevision Premium Content. PTV Premium Content will include PTV News - a daily news and analysis service to be launched in August. Subscription to the service will be free until 30 September, 2009. Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "Television captures and delivers something unique, recognising that business is ultimately about the people in it - whether it's a part of deal making, or discovery and development, or about a company's ability to finance itself. It's not a surprise to us that PharmaTelevision has become 'must view' TV for many senior executives and managers".

Dr Walton continues, "Launch of this new service means we can deliver to our subscribers great television programming and integrated news and analysis information services." PharmaTelevision addresses the current issues and future predictions of the industry, including those of the top companies, through news, analysis, interviews, panels and discussions. Interviewees come from companies such as Johnson & Johnson, Merck & Co., sanofi-aventis, Genzyme, MerckSerono, NICE UK, and Roche. As well as PTV News, current programmes include PharmaVentures Business Review; The Regional Report; The Financial Report; and PharmaDeals(R) Commentaries, and bring the major industry players straight to desktops - on demand from the viewer.

Dr Walton says, "This year, development to PharmaTelevision has been rapid as we meet the demand from our discerning audience. Our subscribers can look forward to significant upgrades that help them uncover further value in the service, and not least will shortly see news services compiled jointly by top experts from both the pharmaceutical and the television world. Subscribers to PharmaTelevision Premium Content can access over 200 high quality interviews and panel discussions filmed since June 2006. Dr Walton concludes, "It's an exciting time for us and our viewers."

About PharmaTelevision(R)

PharmaTelevision (http://www.pharmatelevision.com) is the groundbreaking online TV channel for the pharmaceutical and biotech sector, offering insight, featured interviews, panel discussions and company information. Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts over 200 TV programmes with a truly global audience, 60% of whom are C-suite executives. In 2008, the channel launched a sleek new look and introduced two exciting TV programmes - the Financial Report and the Regional Report, which, together with our well-established TV programmes, help to give our viewers a complete overview of industry trends, analysis including deals, investments and strategic policies within the sector. In 2009, PharmaTelevision will be launching PTV News - a daily summary and analysis of the major news headlines, ensuring that, wherever in the world they are, our audience can stay truly informed.

Testimonials about the value of PharmaTelevision from industry leading figures can be viewed online at http://www.pharmatelevision.com/VideoHandler.aspx?ID=166&Type=flv

A promotional Video about PharmaTelevision can be viewed online at: http://www.pharmatelevision.com/VideoHandler.aspx?ID=270

PharmaTelevision is a part of the business media division of PharmaVentures Ltd (http://www.pharmaventures.com).

Notes to Editors:

About PharmaVentures

A leading results driven organisation, PharmaVentures ( http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company's provides tailored consulting and transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals range of intelligence products that include analysis tools and reports. An innovative business, PharmaVentures additionally provides industry insight through the world's first dedicated online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

For further information, or to receive a demonstration of the new service, please contact:

    Lisa Holloway
    Marketing, PharmaTelevision
    +44-(0)1865-784-177
    lisa.holloway@pharmaventures.com

    Fintan Walton,
    +44-(0)1865-784-187
    fintan.walton@pharmaventures.com



'/>"/>
SOURCE PharmaVentures
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... (LAIs), today announced a development collaboration with the Australian critical medicine company, ... such as schizophrenia. , LAI medicines can offer improved therapeutic benefits over oral ...
(Date:5/5/2016)... ... ... Einstein Medical is proud to announce that it has created ... at the 2016 ASCRS/ASOA Symposium and Congress, which takes place in New Orleans, LA ... Surgery and the American Society of Ophthalmic Administrations will be held at the Ernest ...
(Date:5/5/2016)... ... ... from Friday, May 6 - Sunday, May 8, fifteen elite athletes from Team Semper ... Mountain Bike Camp, hosted in conjunction with WTB and Cannondale in ... who’ll share pro tips with the injured veterans as they rip down some of the ...
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... ... ... intensive lectures and hands-on exercises, the Wharton Seminars for Business Journalists ... a better understanding of key business and economic issues.  This one-day program ...
(Date:5/5/2016)... ... ... Derrin Doty Group has unveiled the latest charity campaign in their ongoing community ... The insurance provider’s caring team has been so moved by the sudden death of ... the flu, that they have decided to extend their original campaign. Compassionate community members ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
(Date:5/3/2016)... Germany , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further ...    Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
Breaking Medicine Technology: